胎儿胰腺周长对妊娠期糖尿病的预测能力
这项在以色列两个超声中心进行的回顾性队列研究纳入195例低危孕妇,于孕20-25周测量胎儿胰腺周长。24例(12.3%)后续诊断为妊娠期糖尿病,其胰腺周长百分位显著高于非妊娠期糖尿病组(82.4±14.6 vs 62.8±27.6,P<0.001)。胰腺周长第80百分位对妊娠期糖尿病的敏感度最高(70.8%),阳性预测值为23.3%,ROC曲线下面积(0.71)高于葡萄糖挑战试验(0.64)。
要点
- 胎儿胰腺周长第80百分位预测妊娠期糖尿病的敏感度为70.8%,阳性预测值为23.3%。
- 妊娠期糖尿病组胎儿胰腺周长百分位显著高于非妊娠期糖尿病组(82.4±14.6 vs 62.8±27.6,P<0.001)。
- 胰腺周长ROC曲线下面积为0.71,高于葡萄糖挑战试验的0.64,仅前者差异有统计学意义(P=0.001)。
核心结论
- 胎儿胰腺周长预测妊娠期糖尿病的阳性预测能力优于葡萄糖挑战试验,测量胰腺周长可识别妊娠期糖尿病高危孕妇。
研究设计与样本
- 回顾性队列研究,纳入以色列两个超声中心2017年至2020年间孕20-25周常规中孕期胎儿解剖筛查的低危孕妇,共195例进入统计分析。
关键影像表现/征象
- 妊娠期糖尿病组胎儿胰腺周长百分位均值±标准差为82.4±14.6,非妊娠期糖尿病组为62.8±27.6,组间差异有统计学意义(P<0.001)。
- 胎儿胰腺周长百分位与估计胎儿体重百分位呈正相关(Pearson相关系数0.243,P=0.001)。
- 24例(12.3%)孕妇后续诊断为妊娠期糖尿病。
诊断标准与关键数值
- 胰腺周长第80百分位预测妊娠期糖尿病的敏感度为70.8%,阳性预测值为23.3%,为各切点中最高。
- 胰腺周长第75百分位预测妊娠期糖尿病的敏感度为79%,特异度为60%,为敏感度与特异度最佳平衡点。
- 葡萄糖挑战试验预测妊娠期糖尿病的特异度为90.2%,阴性预测值为97.9%,均优于胰腺周长两个切点。
- 胰腺周长预测妊娠期糖尿病的ROC曲线下面积为0.71,葡萄糖挑战试验为0.64,仅胰腺周长差异有统计学意义(P=0.001)。
临床应用与阅片要点
- 在中孕期常规胎儿解剖筛查时可测量胎儿胰腺周长,用于识别后续发生妊娠期糖尿病的高危孕妇。
- 胰腺周长第80百分位敏感度最高但阳性预测值仅23.3%,判读时需结合葡萄糖挑战试验结果。
- 葡萄糖挑战试验特异度(90.2%)和阴性预测值(97.9%)较高,胰腺周长不能替代其排除作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To assess the capacity of fetal pancreatic size, before standard blood glucose testing for screening and diagnosis, to predict maternal gestational diabetes mellitus (GDM).
METHODS: This was a retrospective cohort study of low-risk pregnant women recruited during routine second-trimester fetal anatomical screening at 20-25 weeks' gestation at two ultrasound units in Israel between 2017 and 2020. The predictive performance of fetal pancreatic circumference ≥ 80th and ≥ 90th centiles and glucose challenge test (GCT) was examined for the outcome of GDM. The independent-samples t-test was used to compare mean pancreatic circumference centile between pregnancies with GDM and those without GDM. Diagnostic performance was evaluated with 2 × 2 contingency tables and receiver-operating-characteristics (ROC) curves.
RESULTS: Overall, 195 women were selected for statistical analysis. Twenty-four (12.3%) women were diagnosed subsequently with GDM. The mean ± SD fetal pancreatic circumference centile was significantly higher in the GDM group compared with the non-GDM group (82.4 ± 14.6 vs 62.8 ± 27.6; P < 0.001). The pancreatic circumference centile was correlated positively with the estimated fetal weight centile (Pearson's coefficient, 0.243; P = 0.001). The 80th centile cut-off for pancreatic circumference had the highest sensitivity (70.8%) and positive predictive value (23.3%) for future maternal GDM, with the best trade-off between sensitivity and specificity achieved at the 75th centile cut-off (sensitivity, 79%; specificity, 60%). The GCT had better specificity (90.2%) and negative predictive value (97.9%) compared with both cut-offs in pancreatic circumference. The area under the ROC curve was higher for pancreatic circumference compared with GCT (0.71 vs 0.64) and only the former was statistically significant (P = 0.001).
CONCLUSIONS: Fetal pancreatic circumference has a higher positive predictive capacity compared with GCT. Measuring pancreatic circumference can identify pregnancies at high risk for maternal GDM, thereby promoting earlier diagnosis and treatment, decreasing the time period during which the fetus is exposed to high maternal glucose levels and improving infant outcome. © 2024 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Gilboa Y, Geron Y, Perlman S, et al. Predictive capacity of fetal pancreatic circumference for gestational diabetes mellitus. Ultrasound Obstet Gynecol. 2024. PMID: 39087927. doi:10.1002/uog.27719
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。